Markets:

Overview

News

Currencies

International

Treasuries

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

50.88 -0.16 (-0.32%)

Streaming Delayed Price Updated: 12:26 PM EDT, May 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

45 46 Next >

Looking Into GSK's Recent Short Interest ↗

December 18, 2023

Via Benzinga

GSK Awards $1M in COiMMUNITY Initiative Grants to Support Adult Immunization and Health Equity

December 12, 2023

From GSK plc

Via Business Wire

3 cheap 'stock'-ing stuffers Wall Street is bullish on

December 07, 2023

These three companies have Wall Street feeling bullish and are trading under $10, making them ideal ‘stock'-ing stuffers for hard to shop for traders.

Via MarketBeat

Topics Stocks

Why Is Genetic Medicines-Focused Wave Life Sciences Stock Trading Lower Today? ↗

December 07, 2023

Wave Life Sciences Ltd (NASDAQ: WVE) has priced its previously announced underwritten public offering of 20 million shares at $5.00 per share with approximately

Via Benzinga

Price Over Earnings Overview: GSK ↗

November 22, 2023

Via Benzinga

Looking Into GSK's Recent Short Interest ↗

November 20, 2023

Via Benzinga

These biotechs targeting multiple neurodegenerative diseases

December 01, 2023

A growing number of up-and-coming biotech firms are demonstrating the value of expanding a drug's total addressable market.

Via MarketBeat

Competition and Optimism: GSK's CEO Walmsley Foresees Growth Despite Competition In RSV Vaccine Market ↗

November 30, 2023

Emma Walmsley, the Chief Executive Officer of GSK plc (NYSE: GSK), expressed confidence in its respiratory syncytial virus (RSV) vaccine, Arexvy, anticipating sales to surpass £1 billio

Via Benzinga

3 Stocks to Sell for Tax Losses Before the New Year ↗

November 28, 2023

While no one wants to lose in the market, you can be productive with the red ink through stocks to sell for tax losses.

Via InvestorPlace

3 Great Foreign Companies to Invest in Right Now ↗

November 27, 2023

The world is a big place, and many great companies are based outside our U.S. borders.

Via The Motley Fool

GSK Frames A Comeback For Its Multiple Myeloma Drug Following Encouraging Phase 3 Data ↗

November 27, 2023

GSK plc (NYSE: GSK) announced headline

Via Benzinga

Merck's Latest Drug For Chronic Cough Faces FDA Pushback ↗

November 18, 2023

A panel of advisors to the Food and Drug Administration (FDA) reportedly expressed concerns about the efficacy of Merck & Company, Inc.'s (NYSE:

Via Benzinga

Senator's Bearish Tesla Bet Under Scrutiny As He Buys Put Options Ahead Of Elon Musk-Led Company's Q3 Results That Set Stock Slide In Motion ↗

November 17, 2023

Sen. Tommy Tuberville bought 3 tranches of put options to sell Tesla shares at $190 a day ahead of Q3 results that set in motion a stock slump.

Via Benzinga

Diversifying Your Portfolio With Plant-Based Options ↗

November 16, 2023

Investors see profit potential in the plant-based market due to rising consumer demand, ESG focus, and the growth of vegan products in various industries, including pharmaceuticals. However, market...

Via Talk Markets

Major Buyout Firms Eye Sanofi's Consumer Health Division Spinoff Valued Over $20B ↗

November 16, 2023

Sanofi SA (NYSE: SNY) has reportedly initiated talks with Rothschild & Co. to explore the possibility of spinning off its consumer health division, which could potentially value the business at over...

Via Benzinga

Current Analysis: GSK Plc ↗

November 16, 2023

In the pharmaceutical industry, GSK PLC ranks as one of the largest companies by total sales.

Via Talk Markets

Acuitas Challenges CureVac in Legal Tussle Over COVID-19 Vaccine Technology ↗

November 15, 2023

Biotech company Acuitas Therapeutics has filed a lawsuit in Virginia federal court against Germany-based CureVac SE (NASDAQ: CVAC), accusing it of failing to credit Acuitas on patents related to...

Via Benzinga

Topics Intellectual Property Lawsuit

European Drug Regulator Recommends Approval Of GSK's Bone Marrow Cancer Med ↗

November 13, 2023

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency adopted a posi

Via Benzinga

GSK and Queer Eye’s Thom Filicia Partner on Blood Cancer Awareness Initiative

November 13, 2023

From GSK plc

Via Business Wire

6 Nasdaq 100 Stocks Down 40% or More that Will Soar As Much 367% ↗

November 08, 2023

Wall Street is forever optimistic about the future for stocks and pegs these seven Nasdaq 100 stocks as ready for supersonic growth

Via InvestorPlace

GSK is a remedy for the winter investment blahs

November 07, 2023

Pharma stock GSK is a remedy for the winter blahs with a low beta, a high yield, and value for investors. Sales of new drug Arexvy underpin results.

Via MarketBeat

Topics Intellectual Property

3 Healthcare Stocks Getting Help From the Aging Population ↗

November 06, 2023

America's aging population needs chronic conditions treatments, and these healthcare stocks are growing in the quest for healing solutions.

Via InvestorPlace

3 Top Dividend Stock Picks for Steady Income and Capital Appreciation ↗

November 02, 2023

Conservative investors will benefit from these top dividend stock picks that are likely to generate significant returns.

Via InvestorPlace

Moderna Beats Sales Forecasts, But Light Guidance Could Rattle Shares ↗

November 02, 2023

The company issued below-consensus sales views for 2023 and 2024.

Via Investor's Business Daily

GSK Hikes Guidance On The Back Of Its Strong RSV Vaccine Launch ↗

November 01, 2023

The company is rivaling Pfizer, which also gained approval this year for an RSV vaccine.

Via Investor's Business Daily

GSK Lifts Annual Guidance Again Helped By Strong Launch Of RSV Vaccine, Steady Demand For Shingles Shot ↗

November 01, 2023

GSK plc (NYSE: GSK) reported Q3 FY23 s

Via Benzinga

Nasdaq, S&P 500 Futures Slide Ahead Of Fed Decision, Economic Data: Analyst Tells Why November Could Herald 'Good News' ↗

November 01, 2023

U.S. stocks could start Wednesday's session lower as traders stay cautious ahead of the Fed decision and more earnings.

Via Benzinga

Topics Economy Stocks

Johnson & Johnson Offloads Rights For Hepatitis B Candidate To GSK ↗

October 31, 2023

GSK plc (NYSE: GSK) and Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) have

Via Benzinga

Earnings Scheduled For November 1, 2023 ↗

November 01, 2023

Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1.07 per share on revenue of $9.37 billion.

Via Benzinga

Hope for Endometrial Cancer - GSK Drug Proves Effective in Increasing Survival Rates ↗

October 30, 2023

GSK plc (NYSE: GSK)

Via Benzinga

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

45 46 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.